At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 250 enrolled
Drug / intervention
Purified Chick Embryo Cell Inactivated Rabies Vaccinebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IV, Multi-center, Randomized, Open-label Study of PCECV (Rabipur®) Comparing the Immunogenicity and Safety of Two Different Simulated Post Exposure Schedules (Zagreb 2-1-1 Versus Essen Regimen 1-1-1-1-1) in Healthy Indian Subjects
In Brief
A Phase 4 clinical trial evaluating Purified Chick Embryo Cell Inactivated Rabies Vaccine for Rabies. Completed, enrolled 250 participants across 3 sites.
Detailed Summary
This study was planned to establish the non-inferiority of Rabipur administered as simulated post exposure Zagreb schedule as compared to Essen schedule, in healthy Indian adult subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRabies
CountriesIndia
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2011
Enrollment StartJul 2011
Primary CompletionNov 2011
TodayJul 2026
First PostedJun 3, 2011
Enrollment StartJul 1, 2011
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.1 years ago
Interventions
Purified Chick Embryo Cell Inactivated Rabies Vaccinebiological
Two group (Zagreb and Essen) will receive Rabipur vaccine IM according to either Zagreb or Essen schedules.